Beyond the conventional p53-mediated molecular pathway of CDKN2AIP to induce cell senescence, further detailed study demonstrated that CDKN2AIP exerted its anti-tumor effects through interaction with CARM1 and eIF4β. Here, TP53 is linked to neoplasm.